Company / CapEx per Share
ARS Pharmaceuticals, Inc. CapEx per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
-40.7%
vs FY2024
Sector context
#147 of 192
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s capex per share of $0.00 is lower than 77% of companies in the Health Care sector (FY2025). Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -59.4%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +24.1%
- 5-Year CAGR
- -59.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 192This company $0.00 Sector average $3.54
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 40.7% year-over-year.
- Ranks #147 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -40.7% |
| FY2024 | $0.01 | +213.5% |
| FY2023 | $0.00 | +2.9% |
| FY2022 | $0.00 | -4.9% |
| FY2021 | $0.00 | -99.4% |
| FY2020 | $0.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026